Expression of CD133, PAX2, ESA, and GPR30 in invasive ductal breast carcinomas

Abstract

Detecting the expression of CD133, PAX2, ESA, and GPR30 in invasive ductal breast carcinomas may be of help in more accurately predicting the aggressive properties of breast cancer and determining the optimal treatment.